Serious concerns could delay Zocor switch

March 17, 2004

Serious concerns have been expressed about plans to sell statins over the counter, and could hold up the POM to …

Novartis ponders tie-up with Aventis

March 8, 2004

Aventis may have found its 'white knight' to save it from a hostile takeover from Sanofi-Synthelabo, in the shape of …

MMR researchers withdraw claim

March 4, 2004
MMR

Ten doctors who co-authored the controversial UK study which linked the MMR jab to autism have withdrawn their support for …

Making the most of CRM

March 4, 2004

In recent years, pharma companies have spent considerable sums on introducing customer relationship management (CRM). However, our research into the …

Elan fall-out provides launch pad for new company

March 4, 2004

The withdrawal of Elan from Europe has provided a new platform for the launch of a new niche player in …

McClellan’s new job stirs political controversy

March 2, 2004

The head of the FDA Mark McClellan is to quit his post in order to lead the reform of the …

Yamanouchi to buy rivals Fujisawa for $7 billion

February 26, 2004

Japan's third largest pharmaceutical company Yamanouchi is to buy its national rival Fujisawa in a deal worth around $7.7 billion.Rumours …

Persistence pays off as Erbitux finally wins approval

February 23, 2004

Erbitux, the colorectal cancer drug once blighted by one of the biggest ever regulatory scandals has been granted marketing approval …

Cystic fibrosis inhaler to gain European approvals

February 23, 2004

UK drug delivery specialist Profile Therapeutics says it expects marketing approval for its new inhaled cystic fibrosis drug in eight …

Fast track surgery supplier chosen

February 19, 2004

Mercury Healthcare has been chosen as the preferred supplier to run five new NHS fast-track surgery centres.Routine general surgery will …

The Gateway to Local Adoption Series

Latest content